GlaxoSmithKline PLC
9 March 2001
Issued: 9th March 2001, London
Board Change
The Board of GlaxoSmithKline plc announces that Mr. Derek Bonham has decided
not to stand for election as a Non-executive Director of GlaxoSmithKline at
the company's Annual General Meeting to be held on 21st May 2001 ('AGM'). Mr.
Bonham will therefore cease to be a member of the Board with effect from the
conclusion of the AGM.
Mr. Bonham was appointed a Non-executive Director of GlaxoSmithKline plc in
May 2000 and had been a Non-executive Director of Glaxo Wellcome plc since
1995.
Enquiries:
UK Media enquiries: Martin Sutton (020) 8966 8000
Philip Thomson (020) 8966 8000
Alan Chandler (020) 8966 8000
US Media enquiries: Nancy Pekarek (215) 751 7709
Mary Anne Rhyne (919) 483 2839
European Analyst/Investor enquiries: Jennie Younger (020) 8966 8378
Duncan Learmouth (020) 8966 5961
Joan Toohill (020) 8966 8715
Anita Kidgell (020) 8966 8369
US Analyst/ Investor enquiries: Frank Murdolo (212) 308 5185
Tom Curry (215) 751 5419
S M Bicknell
Company Secretary
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.